A common pathway: Asthma and allergic rhinitis

Allergy and Asthma Proceedings

Volumn 23, Issue 6, 2002, Pages 359-365

  Nayak, Anjuli S ^a,b  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASTHMA; DISEASE MANAGEMENT; EVIDENCE BASED MEDICINE; HEALTH SURVEY; HUMAN; INCIDENCE; PATHOPHYSIOLOGY; PERENNIAL RHINITIS; REVIEW; UNITED STATES;

ASTHMA; DISEASE MANAGEMENT; EVIDENCE-BASED MEDICINE; HEALTH SURVEYS; HUMANS; INCIDENCE; RHINITIS, ALLERGIC, PERENNIAL; UNITED STATES;

EID: 0036879143     PISSN: 10885412     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Nimmaggadda SR. Evans R III. Allergy, etiology and epidemiology. Pediatr Rev 20:111-115, 1999.
2. American Lung Association. Prevalence based on revised National Health Interview Survey. Available at. http://www.lungusa.org/data/ data_102000.html. Accessed March 6, 2001.
3. Taylor WR, and Newacheck PW Impact of childhood asthma on health. Pediatrics 90:657-662, 1992.
4. Nathan RA, Meltzer EO, Selner JC, and Storms W. Prevalence of allergic rhinitis in the United States J Allergy Clin Immunol 99(suppl):S808-S814, 1997.
5. Wright AL, Holberg CJ, Martinez FD, et al. Epidemiology of physician-diagnosed allergic rhinitis in childhood. Pediatrics 94:895-901, 1994.
6. McMenamin P. Costs of hay fever in the United States in 1990. Ann Allergy 73:35-39, 1994.
7. Kapsali T, Horowitz E, Diomer F. and Togias A. Rhinitis is ubiquitous in allergic asthmatics. J Allergy Clin Immunol 99:S138, 1997 (Abs).
8. Lombardi C. Passalacqua G, Gargioni S. et al. The natural history of respiratory allergy: a follow-up study of 99 patients up to 10 years. Respir Med 95:9-12, 2001.
9. Settipane RJ, Hagy GW, and Settipane GA. Long-term risk factors for developing asthma and allergic rhinitis: a 23-year follow-up study of college students. Allergy Proc 15:21-25, 1994.
10. Greisner WA III, Settipane RJ, and Settipane GA. Co-existence of asthma and allergic rhinitis: A 23-year follow-up study of college students. Allergy Asthma Proc 19:185-188, 1998.
11. Greisner WA, III, Settipane RJ, and Settipane GA. Natural history of hay fever: A 23-year follow-up of college students. Allergy Asthma Proc 19.271-275, 1998.
12. Greisner WA III, Settipane RJ, and Settipane GA. The course of asthma parallels that of allergic rhinitis: A 23-year follow-up study of college students. Allergy Asthma Proc 21:371-376, 2000.
13. Gaga M, Lambrou P, Papageogiou N, et al. Eosinophils are a feature of upper and lower airway pathology in non-atopic asthma, irrespective of the presence of rhinitis. Clin Exp Allergy 30:663-669, 2000.
14. Togias A. Unique mechanistic features of allergic rhinitis. J Allergy Clin Immunol 106:5599-8604, 2000
15. Ledford DK, and Lockey RF. Allergic rhinitis: understanding the process. J Respir Dis 19:576-584, 1998.
16. Spector SL. Allergic inflammation in upper and lower airways. Ann Allergy Asthma Immunol 83:435-444, 1999.
17. Naclerio RM, Proud D, Togias AG, et al. Inflammatory mediators in late antigen-induced rhinitis. N Engl J Med 313:65-70, 1985.
18. Kay AB. Allergy and allergic diseases; first of two parts. N Engl J Med 344:30-37, 2001.
19. Diamant Z, Grootendorst DC, Veselic-Charvat M, et al. The effect of montelukast (MK-0476), a cysteinyl leukotriene receptor antagonist, on allergen-induced airway responses and sputum cell counts in asthma. Clin Exp Allergy 29:42-51, 1999.
20. Kjellmann N-IM. Is there a place for antihistaminei in the treatment of perennial asthma? Pediatr Allergy Immunol 4(suppl 4):38-43, 1993.
21. Samuelsson B. Leukotnenes: mediators of immediate hypersensitivity reactions and inflammation. Science 220:568-575, 1983.
22. Henderson WR Jr. The role of leukotnenes in inflammation. Ann Intern Med 121-684-697, 1994.
23. Knapp HR, and Murray JJ. Leukotrienes as mediators of nasal inflammation. Adv Prostaglandin Thromboxane Leukot Res 22:279-288, 1994.
24. Donnelly AL, Glass M, Minkwitz MC, and Casale TB. The leukotriene D4-receptor antagonist. ICI 204, 291, relieves symptoms of acute seasonal allergic rhinitis. Am J Respir Crit Care Med 151: 1734-1739, 1995.
25. Malmstrom K, Hampel FC, Philip G, et al. for the Montelukast Spring Rhinitis Investigation Group. Montelukast in the treatment of spring allergic rhinitis in a large, double-blind, randomized, placebocontrolled study. J Allergy Clin Immunol 107:S157, 2001 (Abs 519).
26. Meltzer EO, Malmstrom K. Lu S, et al. Concomitant montelukast and loratadine as treatment for seasonal allergic rhinitis: a randomized, placebo-controlled clinical trial. J Allergy Clin Immunol 105:917-922, 2000.
27. Wilson AM, Orr LC, Sims EJ, and Lipworth BJ. Effects of monotherapy with intra-nasal corticosteroid or combined oral histamine and leukotriene receptor antagonists in seasonal allergic rhinitis. Clin Exp Allergy 31:61-68, 2001.
28. Reicin A, White R., Weinstein SF, et al., for the Montelukast/ Loratadine Study Group. Montelukast, a leukotriene receptor antagonist, in combination with loratadine, a histamine receptor antagonist, in the treatment of chronic asthma. Arch Intern Med 160:2481-2488, 2000.